Cart
sales@molnova.com
BAI1
CAS No. 335165-68-9
BAI1 ( —— )
Catalog No. M20096 CAS No. 335165-68-9
BAI1 (Bax channel blocker) is a potent inhibitor of Bax-mediated mitochondrial cytochrome C release (IC50: 0.52 μM).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 43 | In Stock |
|
| 5MG | 72 | In Stock |
|
| 10MG | 115 | In Stock |
|
| 25MG | 228 | In Stock |
|
| 50MG | 417 | In Stock |
|
| 100MG | 614 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameBAI1
-
NoteResearch use only not for human use.
-
Brief DescriptionBAI1 (Bax channel blocker) is a potent inhibitor of Bax-mediated mitochondrial cytochrome C release (IC50: 0.52 μM).
-
DescriptionBAI1 (Bax channel blocker) is a potent inhibitor of Bax-mediated mitochondrial cytochrome C release (IC50: 0.52 μM).
-
Synonyms——
-
PathwayAngiogenesis
-
TargetBcl-2
-
RecptorBax
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number335165-68-9
-
Formula Weight467.2
-
Molecular FormulaC19H21Br2N3O
-
Purity>98% (HPLC)
-
SolubilityDMSO: 15 mg/mL (32.1 mM);Water: Insoluble
-
SMILESOC(CN1CCNCC1)Cn1c2ccc(Br)cc2c2cc(Br)ccc12
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Bombrun A et al. 36-dibromocarbazole piperazine derivatives of 2-propanol as first inhibitors of cytochrome c release via Bax channel modulation. J Med Chem. 2003 Oct 9;46(21):4365-8.
molnova catalog
related products
-
A-1210477
A-1210477 is a potent, selective Mcl-1 inhibitor that bind to Mcl-1 (Ki=0.45 nM) to disrupt MCL-1-BIM complexes.
-
Paederosidic acid
Paederosidic acid has significant anti-tumor anticonvulsant and sedative effects. Paederosidic acid increases brain gamma-aminobutyric acid and decreases glutamic acid in the brain and it up-regulates expressions of GAD 65 may be a promising future therapeutic agent for treatment of epilepsy.
-
BCL6-IN-6
BCL6-IN-6 is an inhibitor of Bcl-6 and can be used in studies about diffuse large B-cell lymphoma. BCL6-IN-6 blocks the interaction of Bcl-6 with its corepressors and dose-dependently reactivates Bcl-6 target genes.
